These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2496577)

  • 1. Double-blind placebo-controlled evaluation of flunarizine as adjunct therapy in epilepsy with complex partial seizures.
    Alving J; Kristensen O; Tsiropoulos I; Mondrup K
    Acta Neurol Scand; 1989 Feb; 79(2):128-32. PubMed ID: 2496577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind cross-over placebo controlled study of flunarizine in patients with therapy resistant epilepsy.
    Starreveld E; de Beukelaar F; Wilson AF; McLean DR; Findlay HP
    Can J Neurol Sci; 1989 May; 16(2):187-90. PubMed ID: 2731086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flunarizine for treatment of partial seizures: results of a concentration-controlled trial.
    Pledger GW; Sackellares JC; Treiman DM; Pellock JM; Wright FS; Mikati M; Sahlroot JT; Tsay JY; Drake ME; Olson L
    Neurology; 1994 Oct; 44(10):1830-6. PubMed ID: 7936231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind placebo-controlled trial with flunarizine in therapy-resistant epileptic patients.
    Fröscher W; Bülau P; Burr W; Penin H; Rao ML; de Beukelaar F
    Clin Neuropharmacol; 1988 Jun; 11(3):232-40. PubMed ID: 3042126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial.
    Biton V; Berkovic SF; Abou-Khalil B; Sperling MR; Johnson ME; Lu S
    Epilepsia; 2014 Jan; 55(1):57-66. PubMed ID: 24446953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flunarizine as a supplementary medication in refractory childhood epilepsy: a double-blind crossover study.
    Keene D; Whiting S; Humphreys P; Jacob P
    Can J Neurol Sci; 1989 May; 16(2):191-3. PubMed ID: 2731087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind crossover study of cinromide versus placebo in epileptic outpatients with partial seizures.
    Spilker B; Bruni J; Jones M; Upton A; Cato A; Cloutier G
    Epilepsia; 1983 Aug; 24(4):410-21. PubMed ID: 6409599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind placebo-controlled trial of flunarizine as add-on therapy in refractory childhood epilepsy.
    Battaglia A; Ferrari AR; Guerrini R
    Brain Dev; 1991 Jul; 13(4):217-22. PubMed ID: 1957968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lamotrigine extended-release as adjunctive therapy for partial seizures.
    Naritoku DK; Warnock CR; Messenheimer JA; Borgohain R; Evers S; Guekht AB; Karlov VA; Lee BI; Pohl LR
    Neurology; 2007 Oct; 69(16):1610-8. PubMed ID: 17938371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flunarizine as add-on therapy in epilepsy. Crossover study vs placebo.
    Moglia A; Bergamasco B; Di Perri R; Mancia D
    Funct Neurol; 1986; 1(4):547-50. PubMed ID: 3301560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind, placebo controlled, crossover study of lamotrigine in treatment resistant partial seizures.
    Schapel GJ; Beran RG; Vajda FJ; Berkovic SF; Mashford ML; Dunagan FM; Yuen WC; Davies G
    J Neurol Neurosurg Psychiatry; 1993 May; 56(5):448-53. PubMed ID: 8505632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of perampanel in patients with drug-resistant partial seizures after conversion from double-blind placebo to open-label perampanel.
    Montouris G; Yang H; Williams B; Zhou S; Laurenza A; Fain R
    Epilepsy Res; 2015 Aug; 114():131-40. PubMed ID: 26088896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: results from a double-blind, randomized, placebo-controlled trial.
    Ryvlin P; Werhahn KJ; Blaszczyk B; Johnson ME; Lu S
    Epilepsia; 2014 Jan; 55(1):47-56. PubMed ID: 24256083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial.
    Peltola J; Coetzee C; Jiménez F; Litovchenko T; Ramaratnam S; Zaslavaskiy L; Lu ZS; Sykes DM;
    Epilepsia; 2009 Mar; 50(3):406-14. PubMed ID: 19317886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tiagabine: efficacy and safety in adjunctive treatment of partial seizures.
    Crawford P; Meinardi H; Brown S; Rentmeester TW; Pedersen B; Pedersen PC; Lassen LC
    Epilepsia; 2001 Apr; 42(4):531-8. PubMed ID: 11440349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gabapentin as add-on therapy in children with refractory partial seizures: a 12-week, multicentre, double-blind, placebo-controlled study. Gabapentin Paediatric Study Group.
    Appleton R; Fichtner K; LaMoreaux L; Alexander J; Halsall G; Murray G; Garofalo E
    Epilepsia; 1999 Aug; 40(8):1147-54. PubMed ID: 10448830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures.
    Brodie MJ; Duncan R; Vespignani H; Solyom A; Bitenskyy V; Lucas C
    Epilepsia; 2005 Jan; 46(1):31-41. PubMed ID: 15660766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsy.
    French JA; Abou-Khalil BW; Leroy RF; Yacubian EM; Shin P; Hall S; Mansbach H; Nohria V;
    Neurology; 2011 May; 76(18):1555-63. PubMed ID: 21451152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjunctive brivaracetam for uncontrolled focal and generalized epilepsies: results of a phase III, double-blind, randomized, placebo-controlled, flexible-dose trial.
    Kwan P; Trinka E; Van Paesschen W; Rektor I; Johnson ME; Lu S
    Epilepsia; 2014 Jan; 55(1):38-46. PubMed ID: 24116853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.